Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Immunoassay, Anti-Seizure Drug

FDA product code NWM · 5 cleared devices

Class 2 Clinical Toxicology
Regulation
21 CFR 862.3350
Review panel
TX
Implant
No
Life sustaining
No
Third party review
Yes
GMP exempt
No
Clearance span
2005-11-18 – 2021-08-05

To aid in management of patients treated with anti-seizure drug.

↑